NT 10-Q

FORM 12B-25

Company: Processa Pharmaceuticals, Inc.
Filed: November 14, 2017
Period of Report: September 30, 2017
Accession Number: 0001393905-17-000356

View Document ↗ View on SEC.gov ↗